Brief: Redx Pharma Says First Patient Dosed In Phase 2a Trial For RXC007

Redx Pharma

11/10/2022 07:49

Oct 11 (Reuters) - Redx Pharma PLC  REDX.L :
    * REDX PHARMA PLC  - FIRST PATIENT DOSED IN PHASE 2A TRIAL
FOR
RXC007
    * REDX PHARMA PLC - FIRST PATIENT DOSED IN PHASE 2A STUDY
ASSESSING RXC007 AS POTENTIAL TREATMENT FOR PATIENTS WITH
IDIOPATHIC PULMONARY FIBROSIS

Source text for Eikon:  ID:nRSK4067Ca 
Further company coverage:  REDX.L 
 ((Reuters.Briefs@thomsonreuters.com;))